Dr. Ariel Seroussi, MD

Dr. Seroussi practices at Resnick Neuropsychiatric Hospital at UCLA in Los Angeles, California.

Dr. Seroussi's NPI, 1801163530, was assigned on November 23, 2011. Dr. Seroussi graduated from University of California San Francisco School of Medicine in 2011. Dr. Seroussi holds California license A122564.

Dr. Seroussi's primary practice is Resnick Neuropsychiatric Hospital at UCLA, at 150 Ucla Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 267-9308.

Dr. Seroussi's primary practice is Resnick Neuropsychiatric Hospital at UCLA in Los Angeles, California. Dr. Seroussi is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Health. Dmand AI also links Dr. Seroussi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seroussi practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Seroussi's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Seroussi is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dr. Seroussi is licensed in California.

Dmand AI lists ADHD, anxiety, depression, drug use disorders, psychological distress, psychoses, schizophrenia and substance abuse among the conditions Dr. Seroussi treats.

CMS data shows 155 Medicare services from Dr. Seroussi across 3 procedure codes in 2024, for 71 Medicare patients. Medicare paid $11,790 for them.

CMS counts 71 Medicare patients who saw Dr. Seroussi in 2024. The largest group is under 65, with 45 patients. 75% of them have anxiety, and 75% have mood disorders. 58% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Seroussi's median patient age at 36, with 52% women.

In 2024, Dr. Seroussi wrote 128 Medicare Part D claims for 26 patients. 96% of them were for generic drugs. CMS names the drug for 41 of them, across 3 drugs with 11 or more claims each, at $707 in total drug cost. In 2023, CMS named 107 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Seroussi for performance year 2024, reported as part of a group. Dr. Seroussi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Seroussi as offering telehealth.

Dmand AI links 3 papers to Dr. Seroussi, published from 2014 to 2015. Dr. Seroussi's most frequent co-authors are Daniel Murphy Bonnici, MD, Gregory Bruce Leong, MD and William Connor Darby, MD.

CMS Open Payments shows 1 general payment to Dr. Seroussi from 1 drug or device company in 2024. Education make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $27.

Dr. Seroussi graduated from University of California San Francisco School of Medicine in 2011.

Dr. Seroussi is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.